Gynecomastia is very rare during antituberculosis chemotherapy. We describe a 38-year-old male patient who developed a painful gynecomastia following second-line drug therapy for multidrug-resistant pulmonary tuberculosis. Gynecomastia disappeared after stopping the ethionamide. A published literature on antituberculosis-induced gynecomastia is also briefly discussed.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356967 | PMC |
| http://dx.doi.org/10.4103/0976-500X.95532 | DOI Listing |
Publication Analysis
Top Keywords
ethionamide-induced gynecomastia
4
gynecomastia
4
gynecomastia gynecomastia
4
gynecomastia rare
4
rare antituberculosis
4
antituberculosis chemotherapy
4
chemotherapy describe
4
describe 38-year-old
4
38-year-old male
4
male patient
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!